NCT00249288View on ClinicalTrials.gov

Folate Supplementation in Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Schizophrenia
Interventions
DRUG

Folate

Folic acid taken as 2, 1mg capsule daily for 12 weeks

DRUG

Placebo

Placebo taken as 2, 1mg capsule daily for 12 weeks

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Massachusetts General Hospital

OTHER

NCT00249288 - Folate Supplementation in Schizophrenia | Biotech Hunter | Biotech Hunter